...
首页> 外文期刊>Ophthalmology >Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age.
【24h】

Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age.

机译:早发性视网膜病变的早期治疗中的散光研究:到3岁为止的发现。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To examine the prevalence of astigmatism (> or =1.00 diopter [D]) and high astigmatism (> or =2.00 D) at 6 and 9 months corrected age and 2 and 3 years postnatal age, in preterm children with birth weight of less than 1251 g in whom high-risk prethreshold retinopathy of prematurity (ROP) developed and who participated in the Early Treatment for Retinopathy of Prematurity (ETROP) Study. DESIGN: Randomized, controlled clinical trial. PARTICIPANTS: Four hundred one infants in whom prethreshold ROP developed in one or both eyes and who were randomized after they were determined to have a high risk (> or =15%) of poor structural outcome without treatment using the Risk Management of Retinopathy of Prematurity (RM-ROP2) program. Refractive error was measured by cycloplegic retinoscopy. Eyes with additional retinal, glaucoma, or cataract surgery were excluded. INTERVENTION: Eyes were randomized to receive laser photocoagulation at high-risk prethreshold ROP (early treated [ET]) or to be conventionally managed (CM), receiving treatment only if threshold ROP developed. MAIN OUTCOME MEASURES: Astigmatism and high astigmatism at each visit. Astigmatism was classified as with-the-rule (WTR; 75 degrees -105 degrees ), against-the-rule (ATR; 0 degrees -15 degrees and 165 degrees -180 degrees ), or oblique (OBL; 16 degrees -74 degrees and 106 degrees -164 degrees ). RESULTS: The prevalence of astigmatism in ET and CM eyes was similar at each test age. For both groups, there was an increase in prevalence of astigmatism from approximately 32% at 6 months to approximately 42% by 3 years, mostly occurring between 6 and 9 months. Among eyes that could be refracted, astigmatism was not influenced by zone of acute-phase ROP, presence of plus disease, or retinal residua of ROP. Eyes with astigmatism and high astigmatism most often had WTR astigmatism. CONCLUSIONS: By age 3 years, nearly 43% of eyes treated at high-risk prethreshold ROP developed astigmatism of > or =1.00 D and nearly 20% had astigmatism of > or =2.00 D. Presence of astigmatism was not influenced by timing of treatment of acute-phase ROP or by characteristics of acute-phase or cicatricial ROP. These findings reinforce the need for follow-up eye examinations in infants with high-risk prethreshold ROP. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
机译:目的:检查早产儿体重在6个月和9个月以及出生后2和3岁时的散光(>或= 1.00屈光度[D])和高散光(>或= 2.00 D)的患病率。体重不足1251 g的人,其中发生了高风险的早熟性阈值视网膜病变(ROP)并参加了早产儿视网膜病变的早期治疗(ETROP)研究。设计:随机对照临床试验。参与者:401名婴儿的一只或两只眼睛出现了阈前ROP,并且在不使用早产儿视网膜病变风险管理进行治疗的情况下,被确定具有较高的结构结果不良风险(>或= 15%),这些婴儿被随机分配。 (RM-ROP2)程序。通过睫状肌麻痹检影术测量屈光不正。排除了额外的视网膜,青光眼或白内障手​​术的眼睛。干预:在高风险阈值ROP(早期治疗[ET])或常规治疗(CM)的情况下,眼睛随机接受激光光凝术,仅在阈值ROP形成时才接受治疗。主要观察指标:每次就诊时的散光和高度散光。散光分为规则规则(WTR; 75度-105度),规则规则(ATR; 0度-15度和165度-180度)或斜角(OBL; 16度-74度)和106度-164度)。结果:在每个测试年龄,ET和CM眼睛的散光患病率相似。两组的散光患病率均从6个月时的约32%增加到3年时的约42%,主要发生在6到9个月之间。在可以屈光的眼睛中,散光不受急性期ROP区域,正视疾病或ROP视网膜残留的影响。散光和高度散光的眼睛最常出现WTR散光。结论:到3岁时,在高风险门槛ROP上治疗的眼睛中,近43%的散光大于或等于1.00 D,近20%的散光大于或等于2.00D。散光的存在不受治疗时间的影响急性期ROP或急性期或瘢痕性ROP的特征。这些发现增加了对高危门槛ROP婴儿进行眼科随访的必要性。财务披露:作者对本文讨论的任何材料均没有专有或商业利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号